Artificial intelligence as a tool to identify predictive biomarker in immuno-oncology: this systematic review by arsela prelaj and coll. in Annals of Oncology encompasses genomics, radiomics, pathomics, real-world and multimodal data annalsofoncology.org/article/S0923-…

Back in #AIOM23 for the second plenary of the #Apollo 11 network on #lung #cancer #innovative therapies, #AI 25 centres involved and ready to press on in 2024 with the data presented on #singlecell analysis #immuneprofiling #FACS and #radiomics in #Immunotherapy and #Nsclc

This year again, in sync with the XMas countdowm, we are lucky to witness the migration of the wild Milanese Panettone to its natural habitat - late-working offices. Majestic as ever. And yes, it's still crunch time to finish up I3LUNG 's models ! Hanging in there. #AIResearch

Abstracts wanted! Showcase your work in AI for oncology and research by presenting an abstract for the 2nd edition of the AI for Oncology conference, held at Istituto Tumori on 10th May 2024- tinyurl.com/y5x3n4mj Register to the event: events-communication.com/event/ai2024/ #ClinicalAI #AI4Onc24

#TRYTRAC - leadership workshop in Milan! 🚀 During 3 days TRYTRACers had the opportunity to learn about Istituto Tumori  strengths, structure of patient care, research, and technology. Thank's to all participants! Vall d’Hebron Institute of Oncology (VHIO) Gustave Roussy The Netherlands Cancer Institute Karolinska Institutet CRUK Cambridge Institute DKFZ NCT Heidelberg

We are excited to attend the Cancer Core Europe annual meeting together with our Karolinska Institutet colleagues. Thanks Istituto Tumori for hosting! Looking forward to 2 days of networking with our European partners! 🇪🇺 #CCE2024

💥Cancer Core Europe Annual Meeting at Istituto Tumori Leading researchers from DKFZ Gustave Roussy The Netherlands Cancer Institute Vall d’Hebron Institute of Oncology (VHIO) Karolinska Institutet on ✅digital and computational oncology ✅clinical and translational research ✅experimental oncology #CancerResearch #CancerCare

During 2 days in Milan we will discuss the objectives and perspectives for Cancer Core Europe for the coming years. We are looking forward to working to ensure that new developments in cancer research and treatment reach more and more patients. Thanks Istituto Tumori for hosting #CCE2024

Today we celebrated the first day of #CCEAM24 in Milan, Italy. After a review, perspectives and strategic session, attendees enjoyed great flash talks. Looking forward to day 2!  #CCEDART

Excited for #CCESummSchool24 in Translational Cancer Research? Hear from Matthias Fahrner on his experience & takeaways. 🚀 Apr 2024 applications open soon, stay tuned! ℹ️ rb.gy/kdzkwl Vall d’Hebron Institute of Oncology (VHIO) Karolinska Institutet The Netherlands Cancer Institute DKFZ NCT Heidelberg CRUK Cambridge Centre Istituto Tumori

Join us at #CCESummSchool24 🚀 A unique program for junior scientists and clinicians who wish to learn more about #TranslationalCancerResearch with first-class speakers and colleagues from all around the world. More info ➡️ cancercoreeurope.eu/summerschool/

🔬#CCESummSchool24 in Translational Cancer Research returns this year, inviting passionate junior scientists and clinicians to attend this unique educational program. Learn more about it and how to apply ➡️ rb.gy/oqdbkr

🩻 Last week, Mireia Crispin Raquel Perez-Lopez from #CCE Imaging TF participated in the #AI for Oncology Congress organized by Istituto Tumori and AI-ON Lab CRUK Cambridge Centre Vall d’Hebron Institute of Oncology (VHIO) DKFZ NCT Heidelberg The Netherlands Cancer Institute Karolinska Institutet Gustave Roussy

Thank you to everyone who applied to #CCESummSchool24 ! Our Scientific Committee is currently  analysing  the proposals. We will notify the selected candidates the first week of July. Stay tuned 🚀

Very good work executed and presented by Politecnico di Milano partner with Vanja Miskovic & Alberto Ferrarin on the first version of the PDSS tool on the retrospective data. Woop woop hooray 🎉

In Focus: Cancer Core Europe Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally, by Javier Carmona 🇪🇺, Josep Tabernero et al. bit.ly/4cQO7FE

About to kick off #ESMO2024 in Barcelona. Looking fwd to catching up with friends, connecting with new colleagues and establishing new #Partnerships with Cancer Core Europe Learn more about #CancerCoreEurope in our recent paper Cancer Discovery: aacrjournals.org/cancerdiscover… #CancerResearch

🥼 Day 1 of #CCESumSchool24 recap: 🔹Welcome and intro on Cancer Core Europe 🔹Engaging lectures on precision medicine & clinical trials 🔹Cancer prevention sessions 🔹Science speed dating 🔹Workshop: Patients as Research Partners #CCE_DART

Excited to share our new perspective in #ESMORWD, "Oncology Education in the Age of Artificial Intelligence. we advocate that AI literacy has become a relevant skill x oncologists sciencedirect.com/science/articl… thanks to the co-authors Giovanni Scoazec Dyke Ferber and my friend Jakob Nikolas Kather ESMO - Eur. Oncology

Recommended reading 📚Oncology education in the age of artificial intelligence #AI ➡️ t.ly/a19MR ESMO - Eur. Oncology Elsevier by CCE members arsela prelaj Giovanni Scoazec Istituto Tumori - Dyke Ferber Jakob Nikolas Kather NCT Heidelberg DKFZ